MARKET

GWPH

GWPH

GW Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

118.97
-0.15
-0.13%
After Hours: 118.97 0 0.00% 18:04 01/17 EST
OPEN
120.05
PREV CLOSE
119.12
HIGH
121.11
LOW
117.58
VOLUME
896.53K
TURNOVER
--
52 WEEK HIGH
196.00
52 WEEK LOW
95.71
MARKET CAP
3.68B
P/E (TTM)
-66.3599
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GWPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GWPH News

  • Congress and the FDA May Square Off Over CBD
  • MotleyFool.com.16h ago
  • GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know
  • Zacks.1d ago
  • GW Pharma up 2% premarket after CEO interview
  • seekingalpha.1d ago
  • 3 Top Healthcare Stocks That Could Gain 35% — Or More
  • TipRanks.1d ago

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About GWPH

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.
More

Webull offers GW Pharmaceuticals PLC- ADR (GWPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.